Svetlana Lucas
Patrimonio netto: 19 838 $ in data 31/05/2026
Patrimonio netto: 19 838 $ in data 31/05/2026
Dr. Svetlana Lucas is an Independent Director at Jasper Therapeutics, Inc., an Independent Director at aTyr Pharma, Inc. and a Chief Business Officer at Scribe Therapeutics, Inc. She is on the Board of Directors at Jasper Therapeutics, Inc. and aTyr Pharma, Inc. Dr. Lucas was previously employed as a Senior Vice President-Business Development by Tizona Therapeutics, Inc. and a Head-Oncology & Inflammation by Amgen, Inc. She received her undergraduate degree from Moscow State University Lomonosov and a doctorate degree from California Institute of Technology.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/03/2026 | 20.000 ( 0,07% ) | 16 580 $ | 31/05/2026 | |
ATYR PHARMA, INC. 0,01% | 11/05/2026 | 6.000 ( 0,01% ) | 3 258 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ATYR PHARMA, INC. | Direttore/Membro del Consiglio | 28/06/2019 |
| JASPER THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 19/06/2024 |
Scribe Therapeutics, Inc.
Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops CRISPR-based genetic medicines | Corporate Officer/Principal | 01/06/2019 |
| Società | Posizione | Fine |
|---|---|---|
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Corporate Officer/Principal | 01/01/2019 |
| AMGEN INC. | Corporate Officer/Principal | 01/07/2015 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 7 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
aTyr Pharma, Inc.
aTyr Pharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a bio therapeutics company that discovers and develops medicines based on novel biological pathways | Health Technology |
California Institute of Technology
California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Moscow State University Lomonosov
Moscow State University Lomonosov Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Scribe Therapeutics, Inc.
Scribe Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops CRISPR-based genetic medicines | Health Technology |
Jasper Therapeutics, Inc.
Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale